Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
Jean-Louis Georges, Floriane Gilles, Hélène Cochet, Alisson Bertrand, Marie De Tournemire, Victorien Monguillon, Maeva Pasqualini, Alix Prevot, Guillaume Roger, Joseph Saba, Joséphine Soltani, Mehrsa Koukabi-Fradelizi, Jean-Paul Beressi, Cécile Laureana, Jean-François Prost, Bernard Livarek
doi: https://doi.org/10.1101/2020.08.30.20182451
Jean-Louis Georges
1Department of cardiology
Floriane Gilles
1Department of cardiology
Hélène Cochet
1Department of cardiology
Alisson Bertrand
1Department of cardiology
Marie De Tournemire
1Department of cardiology
Victorien Monguillon
1Department of cardiology
Maeva Pasqualini
1Department of cardiology
Alix Prevot
1Department of cardiology
Guillaume Roger
1Department of cardiology
Joseph Saba
1Department of cardiology
Joséphine Soltani
1Department of cardiology
Mehrsa Koukabi-Fradelizi
2Emergency department
Jean-Paul Beressi
3Department of diabetology
Cécile Laureana
4Department of medical information, Centre Hospitalier de Versailles, Le Chesnay, France
Jean-François Prost
1Department of cardiology
Bernard Livarek
1Department of cardiology
Data Availability
All relevant data are within the manuscript and its Supporting Information files
Posted September 01, 2020.
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
Jean-Louis Georges, Floriane Gilles, Hélène Cochet, Alisson Bertrand, Marie De Tournemire, Victorien Monguillon, Maeva Pasqualini, Alix Prevot, Guillaume Roger, Joseph Saba, Joséphine Soltani, Mehrsa Koukabi-Fradelizi, Jean-Paul Beressi, Cécile Laureana, Jean-François Prost, Bernard Livarek
medRxiv 2020.08.30.20182451; doi: https://doi.org/10.1101/2020.08.30.20182451
Positive association of Angiotensin II Receptor Blockers, not Angiotensin-Converting Enzyme Inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia
Jean-Louis Georges, Floriane Gilles, Hélène Cochet, Alisson Bertrand, Marie De Tournemire, Victorien Monguillon, Maeva Pasqualini, Alix Prevot, Guillaume Roger, Joseph Saba, Joséphine Soltani, Mehrsa Koukabi-Fradelizi, Jean-Paul Beressi, Cécile Laureana, Jean-François Prost, Bernard Livarek
medRxiv 2020.08.30.20182451; doi: https://doi.org/10.1101/2020.08.30.20182451
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)